HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of recurrent erythema nodosum leprosum with infliximab.

AuthorsWilliam R Faber, Annigje J Jensema, Wouter F M Goldschmidt
JournalThe New England journal of medicine (N Engl J Med) Vol. 355 Issue 7 Pg. 739 (Aug 17 2006) ISSN: 1533-4406 [Electronic] United States
PMID16914716 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Infliximab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Erythema Nodosum (drug therapy, immunology)
  • Female
  • Humans
  • Infliximab
  • Leprosy, Lepromatous (drug therapy, immunology)
  • Middle Aged
  • Recurrence
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: